Form D · Pharmaceuticals
ACURA PHARMACEUTICALS, INC
Palatine, IL · CIK 0000786947
Offering snapshot reported Jul 28, 2017 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 24, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 28, 2017 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
| Sep 18, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-291687
Source: Form D, filed Jul 28, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Albert W. Brzeczko | Executive |
| Peter A. Clemens | Executive |
| James F. Emigh | Executive |
| Robert B. Jones | Director, Executive |
| George K. Ross | Director |
| Robert Seiser | Executive |
| William Skelly | Director |
| Immanuel Thangaraj | Director |
| Bruce Wesson | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
616 N. North Court
Palatine, IL, 60067
Palatine, IL, 60067